Understanding OR7G3: A Potential Drug Target for Cancer (G390883)
Understanding OR7G3: A Potential Drug Target for Cancer
OR7G3 (OR7G3_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target in the field of cancer. OR7G3 is a member of the OR7G3 family, which is known for its role in cell signaling and division.
The OR7G3 protein is involved in a variety of cellular processes, including cell adhesion, migration, and the regulation of cell growth. It is a transcription factor that has been shown to play a role in the development and progression of many types of cancer, including breast, lung, and ovarian cancer.
One of the key challenges in studying OR7G3 is its complex structure. OR7G3 is a transmembrane protein that is expressed in a variety of human tissues, including blood vessels, neurons, and cancer cells. It consists of an extracellular domain, a transmembrane region, and an intracellular domain.
The extracellular domain of OR7G3 is involved in its cell adhesion and migration functions. It contains a variety of conserved motifs that are involved in these processes, including a N-terminal transmembrane domain that is involved in cell adhesion and a C-terminal region that is involved in migration.
The transmembrane region of OR7G3 is responsible for its regulation of cell growth and the maintenance of cell survival. It contains several key signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are involved in the regulation of cell growth, cell differentiation, and cancer progression.
The intracellular domain of OR7G3 is involved in its ability to interact with other proteins and to regulate gene expression. It contains several key signaling pathways, including the PI3K/Akt pathway and the NF-kappa-B pathway. These pathways are involved in the regulation of cellular signaling pathways, including cell growth, apoptosis, and inflammation.
In conclusion, OR7G3 is a protein that is involved in a variety of cellular processes and has been identified as a potential drug target in the field of cancer. Further research is needed to fully understand its role in cancer development and to develop effective therapies that target OR7G3.
Protein Name: Olfactory Receptor Family 7 Subfamily G Member 3
Functions: Odorant receptor
The "OR7G3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR7G3 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex | ORM1 | ORM2 | ORMDL1 | ORMDL2 | ORMDL3 | OS9 | OSBP | OSBP2 | OSBPL10 | OSBPL11 | OSBPL1A | OSBPL2 | OSBPL3 | OSBPL5 | OSBPL6 | OSBPL7 | OSBPL8 | OSBPL9 | OSCAR | OSCP1 | OSER1 | OSER1-DT | OSGEP | OSGEPL1 | OSGEPL1-AS1 | OSGIN1 | OSGIN2 | OSM | OSMR | OSMR-DT | OSR1 | OSR2 | OST4 | OSTC | OSTCP1 | OSTF1 | OSTF1P1 | OSTM1 | OSTM1-AS1 | OSTN | OSTN-AS1 | OTC | OTOA | OTOAP1 | OTOF
